Merck & Co., Inc. (BVL:MRK)

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of PEN 906.62 billion. The enterprise value is 984.71 billion.

Market Cap	906.62B
Enterprise Value	984.71B

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Dec 15, 2025

Share Statistics

Current Share Class	2.48B
Shares Outstanding	n/a
Shares Change (YoY)	-0.91%
Shares Change (QoQ)	-0.60%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	78.87%
Float	2.48B

Valuation Ratios

The trailing PE ratio is 13.74 and the forward PE ratio is 11.87.

PE Ratio	13.74
Forward PE	11.87
PS Ratio	4.07
PB Ratio	5.04
P/TBV Ratio	17.49
P/FCF Ratio	20.04
P/OCF Ratio	15.32
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.19, with an EV/FCF ratio of 21.77.

EV / Earnings	14.92
EV / Sales	4.56
EV / EBITDA	9.19
EV / EBIT	10.77
EV / FCF	21.77

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.80.

Current Ratio	1.66
Quick Ratio	1.09
Debt / Equity	0.80
Debt / EBITDA	1.30
Debt / FCF	3.17
Interest Coverage	21.34

Financial Efficiency

Return on equity (ROE) is 39.49% and return on invested capital (ROIC) is 19.31%.

Return on Equity (ROE)	39.49%
Return on Assets (ROA)	13.76%
Return on Invested Capital (ROIC)	19.31%
Return on Capital Employed (ROCE)	26.94%
Revenue Per Employee	3.01M
Profits Per Employee	891,794
Employee Count	75,000
Asset Turnover	0.52
Inventory Turnover	2.24

Taxes

In the past 12 months, Merck & Co. has paid 9.61 billion in taxes.

Income Tax	9.61B
Effective Tax Rate	12.71%

Stock Price Statistics

The stock price has increased by +3.74% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+3.74%
50-Day Moving Average	97.80
200-Day Moving Average	86.73
Relative Strength Index (RSI)	81.92
Average Volume (20 Days)	54

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.82

Income Statement

In the last 12 months, Merck & Co. had revenue of PEN 222.71 billion and earned 65.99 billion in profits. Earnings per share was 26.20.

Revenue	222.71B
Gross Profit	173.38B
Operating Income	94.27B
Pretax Income	75.64B
Net Income	65.99B
EBITDA	109.29B
EBIT	94.27B
Earnings Per Share (EPS)	26.20

Balance Sheet

The company has 63.15 billion in cash and 143.45 billion in debt, with a net cash position of -80.30 billion.

Cash & Cash Equivalents	63.15B
Total Debt	143.45B
Net Cash	-80.30B
Net Cash Per Share	n/a
Equity (Book Value)	179.97B
Book Value Per Share	72.27
Working Capital	65.63B

Cash Flow

In the last 12 months, operating cash flow was 59.17 billion and capital expenditures -13.92 billion, giving a free cash flow of 45.24 billion.

Operating Cash Flow	59.17B
Capital Expenditures	-13.92B
Free Cash Flow	45.24B
FCF Per Share	n/a

Margins

Gross margin is 77.85%, with operating and profit margins of 42.33% and 29.63%.

Gross Margin	77.85%
Operating Margin	42.33%
Pretax Margin	33.96%
Profit Margin	29.63%
EBITDA Margin	49.07%
EBIT Margin	42.33%
FCF Margin	20.31%

Dividends & Yields

This stock pays an annual dividend of 11.57, which amounts to a dividend yield of 10.85%.

Dividend Per Share	11.57
Dividend Yield	10.85%
Dividend Growth (YoY)	-0.89%
Years of Dividend Growth	n/a
Payout Ratio	42.60%
Buyback Yield	0.91%
Shareholder Yield	11.76%
Earnings Yield	7.28%
FCF Yield	4.99%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 3.89 and a Piotroski F-Score of 5.

Altman Z-Score	3.89
Piotroski F-Score	5